The tweet was deleted by the author.
But we saved everything 🙂.
Olema Pharmaceuticals has announced the addition of new members to their team as they aim to push forward in the development of transformative cancer therapies.
This strategic move accentuates the company's commitment to innovation and excellence in oncology treatment research. By expanding their team, Olema Pharmaceuticals seeks to harness diverse expertise to accelerate therapeutic progress in the fight against cancer.
Olema Pharmaceuticals’ commitment to advancing cancer therapeutics builds on a foundation established by recent clinical milestones, including the presentation of new data on palazestrant at ESMO25. This strategic expansion also reflects the company’s continued pursuit of oncology innovation, as highlighted during its active engagement at ESMO 2025, signaling a robust trajectory in the development of next-generation cancer therapies.